Join
Live feed
·
PRReleasevia Quantisnow
Cellectis S.A. logo

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
CLLS· Cellectis S.A.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLLS (Cellectis S.A.) and more on Quantisnow.